Calluna Pharma successfully completes Phase 1 clinical study of CAL101, a first-in-class therapeutic for fibrotic and fibro-inflammatory indications
Calluna Pharma AS (Calluna), a medical stage biotechnology firm pioneering first-in-class antibodies to deal with inflammatory and fibrotic illnesses, right ...
